Tuesday September 22, 2020

Steady UDG gets a clean bill of health

I held my nerve when UDG Healthcare’s share price plummeted, and the recent annual report vindicated my faith, with plenty of cause for medium-term optimism

2nd December, 2018
The annual general meeting of UDG in 2016: members of the board have shown an impressive financial commitment to the company Pic: Fergal Phillips

Until a few months ago, UDG Healthcare was the second-best performing asset in my equity portfolio. In February 2015, I bought the shares at £4.16. They hit a peak at £9.40 in May this year so, notwithstanding the drop in sterling since my purchase, I wasn’t complaining. With a sterling book profit of 125 per cent, the currency loss against the euro was easily absorbed.

However, the recent downward trend in the company’s share price...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Related Stories

Demand continues to outstrip supply in both residential and PRS markets, while developers adapt new build designs to take the pandemic into account

Tina-Marie O'Neill | 2 weeks ago

Several strategic changes offer an opportunity for positive reform of planning and development

Niall Byrne | 2 weeks ago

The United States cannot defeat the pandemic like a military foe but it can learn from looking back at its post-war economic recovery

Todd G Buchholz | 1 month ago